Experience

Agility across:

Product lifecycle – Discovery/early development, Phase 1 – 3, launch, lifecycle management
Roles – Product strategy, market access, health outcomes, marketing, sales
Customer groups – patient, payer, HCP
Disease areas – Immunology (Rheumatology, Inflammatory Bowel Disease, Dermatology, Respiratory), Neurology (MS & Pain), Rare Disease, Oncology and Haematology, Infectious Disease (HIV, Malaria Covid-19)
Geographies – local (UK/Ire & Nordics), regional (EU & International) and global (inc. US, EU, JP, CAN, CN, UMICs & LMICs)

Project Expertise

Strategic planning: Significant experience building insight and synthesising this as part of strategic and operational planning to drive success, by leveraging opportunities and mitigating risks.
Evidence planning and generation: Direct experience building Therapeutic Value Propositions and associated evidence plans to support strategic development activities. This includes identifying and bridging evidence gaps at local, regional and global levels.
Analytical capability: Experience in forecasting and building investment/business cases; Modelling from a cost-utility/effectiveness and budget impact perspective; Price governance and managing IRP; Profit and Loss management
Value communication: Significant experience across multiple roles involving planning, delivery and use of evidence communication, across a wide variety of channels/uses and to various customer groups. ABPI commercial signatory for promotional activities.
Global healthcare environment: Having worked in LOC, regional and global roles across different customer groups I have a broad understanding of the complexities that exist in supporting healthcare innovation across economies, health systems and archetypes. This includes experience in driving access and pricing activities at local and regional levels.

Organisations: